Drugs

Orforglipron, a GLP-1 receptor agonist in tablet form, has proven effective in treating obesity in a phase 3 trial, offering a potential alternative to injectable treatments like Wegovy and Ozempic.

An expert panel recently developed Canadian consensus recommendations for managing male and female pattern hair loss (androgenetic alopecia).

Tirzepatide injection (Zepbound KwikPen) is now available in Canada for chronic weight management.

A large Swedish study published in the BMJ found methylphenidate is associated with a significant reduction in suicidal behavior, substance use, transport accidents and crime.

U.S. officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.

First aryl hydrocarbon receptor agonist results in downregulation of proinflammatory cytokines, skin-barrier normalization and antioxidant activity.

Examine your workflow and see where pharmacists’ time can be freed up and refocused into caring for patients and providing prescribing services.

A review of new launches, new indications, new dosage forms and Health Canada advisories.